Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients-Reference-Cited by-同舟云学术

Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients

Published:2019-04-05 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nitta Sayuri,Asahina Yasuhiro,Kato Takanobu,Tsuchiya Jun,Inoue-Shinomiya Emi,Sato Ayako,Tsunoda Tomoyuki,Miyoshi Masato,Kawai-Kitahata Fukiko,Murakawa Miyako,Itsui Yasuhiro,Nakagawa Mina,Azuma Seishin,Kakinuma Sei,Hikita Hayato,Takehara Tetsuo,Watanabe Mamoru

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-42114-z.pdf

Reference46 articles.

1. Webster, D. P., Klenerman, P. & Dusheiko, G. M. Hepatitis C. Lancet 385, 1124–1135 (2015).

2. Gower, E., Estes, C., Blach, S., Razavi-Shearer, K. & Razavi, H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45–S57 (2014).

3. Pawlotsky, J. M. New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges. Gastroenterology 146, 1176–1192 (2014).